Advancements in Viral Hepatitis From EASL 2022
Listen to expert insights from Nancy Reau, MD, on updates and new viral hepatitis data from EASL 2022, including HBV novel therapeutics in development, therapeutic vaccination for HBV, emerging treatments for HDV, HCV care cascade, and the need for HCC monitoring post HCV cure.
Decera Clinical Education Infectious Disease Podcast · Nancy Reau MD
Audio is streamed directly from the publisher (afp-928689-injected.calisto.simplecastaudio.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
In this episode, Nancy Reau, MD, discusses new viral hepatitis data from EASL 2022, including:
- Novel therapeutics for HBV
- Therapeutic vaccination for HBV
- Emerging treatment options for HDV
- HCV care cascade
- HCC monitoring after HCV cure
Presenter:
Nancy Reau, MD
Professor of Medicine
Chief, Section of Hepatology
Associate Director, Solid Organ Transplantation
Richard B. Capps Chair of Hepatology
Rush University Medical Center
Chicago, Illinois
Follow along with the downloadable slideset at:
https://bit.ly/3yJAruD
Link to full program:
https://bit.ly/3IeUapm
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.